This paper describes some of the processing issues for extruding salicylic acid-based polymer prodrugs into fibers for medical devices. Polymeric prodrugs, in which a drug is polymerized in a degradable polymer that delivers controlled quantity of the drug to a targeted site in the body as the device degrades, are a new approach to controlled release. Hollow fibers were produced by solution spinning. Solid fibers were formed by melt processing. The salicylic acid polymers exhibited shear-thinning behavior. The viscosity exhibited pronounced temperature dependence.
Volume Subject Area:
Textile Engineering
This content is only available via PDF.
Copyright © 2003
by ASME
You do not currently have access to this content.
